Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen

Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen

<strong>Objective: <br></strong> Recycling tenofovir and lamivudine/emtricitabine (XTC) with dolutegravir would provide a more tolerable, affordable, and scalable second-line regimen than dolutegravir with an optimized nucleoside reverse transcriptase inhibitor (NRTI) backbone. We...

Full description

Bibliographic Details
Main Authors: Keene, CM, Griesel, R, Zhao, Y, Gcwabe, Z, Sayed, K, Hill, A, Cassidy, T, Ngwenya, O, Jackson, A, van Zyl, G, Schutz, C, Goliath, R, Flowers, T, Goemaere, E, Wiesner, L, Simmons, B, Maartens, G, Meintjes, G
Format: Journal article
Language:English
Published: Lippincott, Williams and Wilkins 2021

Similar Items

Similar Items